BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8993560)

  • 1. Protein phosphorylation by peroxisome proliferators: species-specific stimulation of protein kinases and its role in PP-induced transcriptional activation.
    Motojima K; Passilly P; Jannin B; Latruffe N
    Ann N Y Acad Sci; 1996 Dec; 804():413-23. PubMed ID: 8993560
    [No Abstract]   [Full Text] [Related]  

  • 2. Peroxisome proliferators: species differences in response of primary hepatocyte cultures.
    Elcombe CR; Bell DR; Elias E; Hasmall SC; Plant NJ
    Ann N Y Acad Sci; 1996 Dec; 804():628-35. PubMed ID: 8993577
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypolipidemic effect of peroxisome proliferators. Transcriptional suppression of apolipoprotein C-III.
    Hertz R; Bishara-Shieban J; Bar-Tana J
    Ann N Y Acad Sci; 1996 Dec; 804():731-3. PubMed ID: 8993607
    [No Abstract]   [Full Text] [Related]  

  • 4. Peroxisome proliferators induce mouse liver stearoyl-CoA desaturase 1 gene expression.
    Miller CW; Ntambi JM
    Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9443-8. PubMed ID: 8790349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic peroxisome proliferators induce morphologic transformation of Syrian hamster embryo cells, but not peroxisomal beta oxidation.
    Sanner T; Mikalsen SO; Rivedal E
    Prog Clin Biol Res; 1991; 369():77-89. PubMed ID: 1946545
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential proto-oncogene mRNA induction from rats treated with peroxisome proliferators.
    Cherkaoui Malki M; Lone YC; Corral-Debrinski M; Latruffe N
    Biochem Biophys Res Commun; 1990 Dec; 173(3):855-61. PubMed ID: 2268348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate.
    Reddy JK; Krishnakantha TP
    Science; 1975 Nov; 190(4216):787-9. PubMed ID: 1198095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment with peroxisome proliferators protects mice against some but not all hepatotoxins.
    Nicholls-Grzemski FA; Burcham PC; Calder IC; Priestly BG
    Ann N Y Acad Sci; 1996 Dec; 804():742-4. PubMed ID: 8993611
    [No Abstract]   [Full Text] [Related]  

  • 9. Peroxisome enzyme modification and oxidative stress in rat by hypolipidemic and antiinflammatory drugs.
    Rivero A; Monreal JI; Gil MJ
    Rev Esp Fisiol; 1994 Dec; 50(4):259-68. PubMed ID: 7754169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of hypolipidemic peroxisome proliferators on the induction of sister chromatid exchanges.
    Linnainmaa K
    Basic Life Sci; 1984; 29 Pt B():965-74. PubMed ID: 6397193
    [No Abstract]   [Full Text] [Related]  

  • 11. Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators.
    Reddy JK; Goel SK; Nemali MR; Carrino JJ; Laffler TG; Reddy MK; Sperbeck SJ; Osumi T; Hashimoto T; Lalwani ND
    Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1747-51. PubMed ID: 3456610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased liver-specific expression of catalase in transgenic mice.
    Nilakantan V; Li Y; Spear BT; Glauert HP
    Ann N Y Acad Sci; 1996 Dec; 804():542-53. PubMed ID: 8993572
    [No Abstract]   [Full Text] [Related]  

  • 13. Suppression of rat glutathione transferase P expression by peroxisome proliferators: interaction between Jun and peroxisome proliferator-activated receptor alpha.
    Sakai M; Matsushima-Hibiya Y; Nishizawa M; Nishi S
    Cancer Res; 1995 Nov; 55(22):5370-6. PubMed ID: 7585603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A protein histidine kinase induced in rat liver by peroxisome proliferators. In vitro activation by Ras protein and guanine nucleotides.
    Motojima K; Goto S
    FEBS Lett; 1993 Mar; 319(1-2):75-9. PubMed ID: 8454063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent peroxisome proliferators inhibit beta-oxidation in the isolated perfused rat liver.
    Bojes HK; Thurman RG
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):322-7. PubMed ID: 8887448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbody proliferation in liver induced by nafenopin, a new hypolipidemic drug: comparison with CPIB.
    Reddy J; Svoboda D; Azarnoff D
    Biochem Biophys Res Commun; 1973 May; 52(2):537-43. PubMed ID: 4711169
    [No Abstract]   [Full Text] [Related]  

  • 17. Specific repression of transthyretin gene expression in rat liver by a peroxisome proliferator clofibrate.
    Motojima K; Goto S; Imanaka T
    Biochem Biophys Res Commun; 1992 Oct; 188(2):799-806. PubMed ID: 1280124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration in gene expression of branched-chain keto acid dehydrogenase kinase but not in gene expression of its substrate in the liver of clofibrate-treated rats.
    Paul HS; Liu WQ; Adibi SA
    Biochem J; 1996 Jul; 317 ( Pt 2)(Pt 2):411-7. PubMed ID: 8713066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a catalase-negative sub-population of peroxisomes induced in mouse liver by clofibrate.
    Klucis E; Crane DI; Hughes JL; Poulos A; Masters CJ
    Biochim Biophys Acta; 1991 Jul; 1074(2):294-301. PubMed ID: 1676600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zonal heterogeneity of peroxisome proliferation in rat liver.
    Fahimi HD; Beier K; Lindauer M; Schad A; Zhan J; Pill J; Rebel W; Völkl A; Baumgart E
    Ann N Y Acad Sci; 1996 Dec; 804():341-61. PubMed ID: 8993555
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.